Brief description: GSK and Save the Children announced the launch of their fourth annual $1 million Healthcare Innovation Award that rewards innovations in healthcare that have helped to reduce child deaths in developing countries.
Application Deadline: 7th September, 2016
Offered annually? Yes
Eligible Countries: Any
About the Award: The Healthcare Innovation Award is looking for innovations focused on providing healthcare solutions to children under-five, working to reduce child mortality rates within developing countries.
GSK and Save the Children are committed to working together to help save the lives of one million children. As part of the global partnership between GSK and Save the Children, we are pleased to announce the launch of the fourth annual Healthcare Innovation Award which will provide USD$ 1 million to reward organisations practicing innovative approaches for increasing and improving access to healthcare for children who are the hardest to reach. The organisations judged to extend the reach of health systems in the most innovative and effective ways will be eligible for an Award of up to USD$ 400,000.
Eligible innovative organisations can come from the non-profit, private or public sector, if both the organisation and the innovation are from the developing world. Nominations can be submitted by the organisation themselves, or an organisation may be nominated by a third-party organisation or individual, through a brief questionnaire found within the detailed guidelines.
Offered Since: 2012
Eligibility: For the Healthcare Innovation Award’s fourth year, special attention will be given to innovations that focus on reaching the hardest to reach children. Extraordinary progress has been made in recent years to reduce the number of children dying before their fifth birthday. Despite this progress, more than five million children still die each year before their fifth birthday, and millions of children are being left behind because of their gender, poverty, or ethnic identity; because they live in remote areas or urban slums; or because they are caught up in conflicts. The HIA this year welcomes ideas for ways in which these children can be reached.
- Represent innovations being developed or implemented by organisations in countries classified as ‘low’, ‘lower-middle’, through to ‘upper-middle’ income by the World Bank. See the World Bank classifications here.
- Describe an innovative approach or process applied to under-5 child survival that can demonstrate impact within an eligible country.
- Provide proven and successful results in the two years preceding the nomination.
- Be an organisation (public, private, or non-profit), academic/research institution, or healthcare facility.
- More than one eligible organisation can be jointly nominated, if the eligible innovation is a joint project.
- More than one eligible innovation can be nominated from one eligible organisation.
- A separate form should be submitted for each nominee.
- You may nominate your own organisation or an organisation with which you have no affiliation, but you must inform the organisation that it has been nominated, secure their consent to participate, and provide contact details for that organisation.
- Employees of the Save the Children and GSK, any of their group companies, and any other person directly connected with the HIAs or the Awards are excluded from being a Nominee. Employees of GSK and Save the Children are excluded from being Nominators.
Nominees may not be individuals or national government bodies. However, institutions funded by governments may be nominees (such as universities, think-tanks, and QUANGOs).
Number of Awardees: Not specified
Value of Award: Winners of this years’ award will benefit from the following:
- A cash donation from a USD$1 million Award fund that has been made available by GSK
- Promotion through public award announcements and international media coverage
- A ‘Roundtable’ event in their local community that will convene interested and relevant stakeholders from the public, private and non-profit sectors to provide a support network that can help improve and grow the innovation
- Potential additional support may include volunteer and/or technical assistance from GSK and Save the Children staff and country offices
Duration of Award: Award winners selected by GSK and Save the Children will be publically announced and their innovative practices promoted within 8 months of the end of the nomination period.
How to Apply:
Award Provider: GlaxoSmithKline Plc